HealthQuill COVID-19
Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to 49 nations in Africa.
Drugs Health Pharma

Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA

Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.

Read More
The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according to a statement from the regulator.
Drugs Health Pharma

Novavax’s vaccine targeting JN.1 strain of Covid-19 virus gets FDA approval 

The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according.

Read More
The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which incorporates a new component to fight a variant of the virus.
Drugs Health Pharma

FDA approves new Covid-19 jabs before fall and winter in the United States

The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which.

Read More
Vaccinations have saved more than 1.6 million lives in the WHO European Region and Covid-19 is lurking around the world menacingly with its new variants, according to the global health agency.
Drugs Health Pharma

Covid-19 vaccines saved 1.6 million lives in Europe, most in Omicron wave

Vaccinations have saved more than 1.6 million lives in the WHO European Region and Covid-19 is lurking around the world menacingly with its.

Read More
The WHO’s event-based surveillance system has reported that at least 40 athletes participating in the Olympic Games in France had tested positive for Covid-19 or other respiratory illnesses.
Drugs Health Pharma

WHO: 40 athletes participating in Olympic Games test Covid-19 positive

The WHO’s event-based surveillance system has reported that at least 40 athletes participating in the Olympic Games in France had tested positive for.

Read More
The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely matching variants circulating in humans, according to a study.
Drugs Health Pharma

Backyard species in US gets Covid-19 through human-to-animal spread

The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely.

Read More
Argentina’s Sinergium Biotech will share its technology and expertise to manufacture bird flu vaccine with partners in low and middle-income countries in case of a pandemic, bolstering preparedness efforts, according to the WHO.
Drugs Health Pharma

Sinergium to share H5N1 vaccine technology with low-income nations

Argentina’s Sinergium Biotech will share its technology and expertise to manufacture bird flu vaccine with partners in low and middle-income countries in case.

Read More
The European Medicines Agency has allowed marketing authorisation for the Covid-19 variant vaccine made by Pfizer and BioNTech SE for children aged six months and older, according to a joint statement.
Drugs Health Pharma

Pfizer, BioNTech gets EMA marketing nod for variant Covid-19 vaccine

The European Medicines Agency has allowed marketing authorisation for the Covid-19 variant vaccine made by Pfizer and BioNTech SE for children aged six.

Read More
Negotiations at reaching a global accord to help fight pandemics better will conclude by 2025 or “earlier if possible at a special session of the World Health Assembly in 2024,” according to the World Health Organization.
Drugs Health Pharma

Global pandemic accord may see the light of day in 2025, ‘or earlier’: WHO

Negotiations at reaching a global accord to help fight pandemics better will conclude by 2025 or “earlier if possible at a special session.

Read More
Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative unveiled in October last year, when sales of its Covid-19 vaccine plummeted.
Drugs Health Pharma

Pfizer Inc. unveils a new $1.5 billion plan to cut costs as vaccine sales fall

Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative.

Read More
X